CN Patent

CN112585166A — 用pd-1轴结合拮抗剂、铂剂和拓扑异构酶ii抑制剂治疗肺癌的方法

Assigned to F Hoffmann La Roche AG · Expires 2021-03-30 · 5y expired

What this patent protects

本公开提供了用于治疗个体的肺癌(诸如小细胞肺癌，例如广泛期小细胞肺癌)的方法。所述方法包括向所述个体施用PD‑1轴结合拮抗剂(诸如抗PD‑L1抗体，例如阿特珠单抗)、铂剂(例如，顺铂或卡铂)和拓扑异构酶II抑制剂(例如，依托泊苷)。

USPTO Abstract

本公开提供了用于治疗个体的肺癌(诸如小细胞肺癌，例如广泛期小细胞肺癌)的方法。所述方法包括向所述个体施用PD‑1轴结合拮抗剂(诸如抗PD‑L1抗体，例如阿特珠单抗)、铂剂(例如，顺铂或卡铂)和拓扑异构酶II抑制剂(例如，依托泊苷)。

Drugs covered by this patent

Patent Metadata

Patent number
CN112585166A
Jurisdiction
CN
Classification
—
Expires
2021-03-30
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.